Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial.

Mfinanga, S; Chanda, D; Kivuyo, SL; Guinness, L; Bottomley, C; Simms, V; Chijoka, C; Masasi, A; Kimaro, G; Ngowi, B; +30 more... Kahwa, A; Mwaba, P; Harrison, TS; Egwaga, S; Jaffar, S; REMSTART trial team; , COLLABORATORS; Chale, P; Kigocha, O; Shirima, RP; Lema, Y; Kasubi, M; Mathania, M; Makuchilo, M; Mziray, F; Alway, C; Rwezaura, L; Mgohamwenda, J; Minde, J; Luhimbo, T; Biseko, M; Kapesa, E; Shoo, W; Barankena, A; Mzyece, J; Chanda, R; Salim, E; Kashongore, G; Kapotwe, V; Manan, D; (2015) Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial. Lancet, 385 (9983). pp. 2173-82. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(15)60164-7

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S0140-6736(15)60164-7

Abstract

Share

Download

Filename: Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia.docx

Licence: Copyright the publishers

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar